Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

Cited by (1,007)

Items 301–400 of 1,007

1. Management of Hepatic Complications in HIV‐Infected Persons
   Mark Sulkowski · 2008 · The Journal of Infectious Diseases
2. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis European Association for the Study of the Liver ⇑ , Asociación Latinoamericana para el Estudio del Hígado
   Laurent Castéra, Henry Lik‐Yuen Chan, Yuen Chan, Marco A. Arrese, Kwang‐Hyub Han · 2015
3. Assessing Liver Fibrosis Using the FIB4 Index in the Community Setting
   Albert Blanco‐Grau, Pablo Gabriel-Medina, Francisco Rodríguez-Algarra, Yolanda Villena-Ortiz, Rosa María López, Salvador Augustín, Mònica Pons, Luz-Maria Cruz, Ariadna Rando‐Segura, Belén Enfedaque et al. · 2021 · Diagnostics
4. Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan
   Tsai, Pei-Chien, Kuo, Hsing-Tao, Hung, Chao-Hung, Tseng, Kuo-Chih, Lai, Hsueh-Chou, Peng, Cheng-Yuan, Wang, Jing-Houng, Chen, Jyh-Jou, Lee, Pei-Lun, Chien, Rong-Nan et al. · 2023 · Journal of Hepatology
5. The nonalcoholic fatty liver disease (NAFLD) fibrosis score, cardiovascular risk stratification and a strategy for secondary prevention with ezetimibe
   Tracey G. Simon, Kathleen E. Corey, Christopher Paul Cannon, Michael A. Blazing, Jeong‐Gun Park, Michelle L. O’Donoghue, Raymond T. Chung, Robert Patrick Giugliano · 2018 · International Journal of Cardiology
6. Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients
   Sven Francque, An Verrijken, Ilse L. Mertens, Guy Hubens, Eric Van Marck, Paul A. Pelckmans, Peter P. Michielsen, Luc Van Gaal · 2012 · Clinical Gastroenterology and Hepatology
7. Liver fibrosis and fatty liver in Asian HIV‐infected patients
   Grace Chung-Yan Lui, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Chiu‐Wing Winnie Chu, C.‐K. Wong, I. M. H. Yung, R. Y. K. Wong, Shiu Lun Au Yeung, D. K.‐W. Yeung, Catherine S. K. Cheung et al. · 2016 · Alimentary Pharmacology & Therapeutics
8. Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices
   Christophe Cassinotto, Anne Charrie, Amaury Mouries, Bruno Lapuyade, Jean‐Baptiste Hiriart, Julien Vergniol, Delphine Gaye, Arnaud Hocquelet, Maude Charbonnier, Juliette Foucher et al. · 2015 · Digestive and Liver Disease
9. Screening for therapeutic trials and treatment indication in clinical practice: MACK ‐3, a new blood test for the diagnosis of fibrotic NASH
   Jérôme Boursier, Rodolphe Anty, Luisa Vonghia, V. Moal, Thomas Vanwolleghem, Clémence M. Canivet, S. Michalak, Stéphanie Bonnafous, Peter P. Michielsen, Frédéric Oberti et al. · 2018 · Alimentary Pharmacology & Therapeutics
10. Association between liver fibrosis scores and the risk of mortality among patients with coronary artery disease
    Qian Chen, Qing Li, Dan Li, Xuechen Chen, Zhaomin Liu, Gang Hu, Jingfeng Wang, Wenhua Ling · 2020 · Atherosclerosis
11. Liver Fibrosis with Two-dimensional US Shear-Wave Elastography in Participants with Chronic Hepatitis B: A Prospective Multicenter Study
    Yongyan Gao, Jian Zheng, Ping Liang, Minghui Tong, Jiabing Wang, Changjun Wu, Xin He, Changzhu Liu, Shumei Zhang, Liping Huang et al. · 2018 · Radiology
12. Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
    Arjun Narayan Ajmer Jayaswal, Christina Levick, Emmanuel Anandraj Selvaraj, Andrea Dennis, Jonathan Booth, Jane D Collier, Jeremy Cobbold, Elizabeth M. Tunnicliffe, Matthew Kelly, Eleanor J. Barnes et al. · 2020 · Liver International
13. NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study
    Stephen A. Harrison, Vlad Ratziu, Jérémy Magnanensi, Yacine Hajji, Sylvie Deledicque, Zouher Majd, Christian Rosenquist, Dean W. Hum, Bart Staels, Quentin Mark Anstee et al. · 2023 · Journal of Hepatology
14. Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings
    Chul‐min Lee, Eileen Laureal Yoon, Mimi Kim, Bo-Kyeong Kang, Seon Cho, Eun‐Hee Nah, Dae Won Jun · 2023 · Hepatology
15. Medical ICU Admission Diagnoses and Outcomes in Human Immunodeficiency Virus–Infected and Virus–Uninfected Veterans in the Combination Antiretroviral Era*
    Kathleen M. Akgün, Janet P. Tate, Margaret A. Pisani, Terri R. Fried, Adeel Ajwad Butt, Cynthia L. Gibert, Laurence Huang, Maria C. Rodriguez‐Barradas, David Rimland, Amy C. Justice et al. · 2013 · Critical Care Medicine
16. Assessment of Allograft Fibrosis by Transient Elastography and Noninvasive Biomarker Scoring Systems in Liver Transplant Patients
    Susanne Beckebaum, Speranţa Iacob, Christian G. Klein, Alexander Dechêne, Joy Varghese, Hideo Andreas Baba, Georgios Charalambos Sotiropoulos, Andreas Paul, Guido Gerken, Vito Rosario Cicinnati · 2010 · Transplantation
17. A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health
    Ahmad Moolla, Kenzo Motohashi, Thomas Marjot, Amelia Shard, Mark Andrew Ainsworth, Alastair McIntosh Gray, Rury R. Holman, Michael Pavlides, John Denis Ryan, Jeremy Tomlinson et al. · 2019 · Frontline Gastroenterology
18. Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
    Jirapinyo, Pichamol, McCarty, Thomas R., Dolan, Russell D., Shah, Raj, Thompson, Christopher C. · 2022 · Clinical Gastroenterology and Hepatology
19. Clinical significance of serum Wisteria floribunda agglutinin positive Mac‐2‐binding protein level and high‐sensitivity C‐reactive protein concentration in autoimmune hepatitis
    Hiroki Nishikawa, Hirayuki Enomoto, Yoshinori Iwata, Kunihiro Hasegawa, Chikage Nakano, Ryo Takata, Takashi Nishimura, Kazunori Yoh, Nobuhiro Aizawa, Yoshiyuki Sakai et al. · 2015 · Hepatology Research
20. Effectiveness of Ipragliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor, as a Second-line Treatment for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus Who Do Not Respond to Incretin-Based Therapies Including Glucagon-like Peptide-1 Analogs and Dipeptidyl Peptidase-4 Inhibitors
    Takamasa Ohki, Akihiro Isogawa, Nobuo Toda, Kazumi Tagawa · 2016 · Clinical Drug Investigation
21. Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease
    Michelle T. Long, Sanil Gandhi, Rohit Seth Loomba · 2020 · Metabolism
22. Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone
    Kefang Yao, Jia‐Cheng Liu, Jian Wang, Xiaomin Yan, Juan Xia, Yue Yang, Weihua Wu, Yong Liu, Yuxin Chen, Zhaoping Zhang et al. · 2021 · Journal of Viral Hepatitis
23. Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis
    Mamatha Bhat, Mahmood Tazari, Giada Sebastiani · 2017 · PLoS ONE
24. Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection
    Monia Mendeni, Emanuele Focà, D. Gotti, Nicoletta Ladisa, Gioacchino Angarano, Laura Albini, Filippo Castelnuovo, G. Carosi, Eugenia Quirós-Roldán, Carlo Torti · 2011 · Clinical Infectious Diseases
25. Validation of Hepascore, Compared With Simple Indices of Fibrosis, in Patients With Chronic Hepatitis C Virus Infection in United States
    Laren S. Becker, Wael Antoine Salameh, Anthony D. Sferruzza, Ke Zhang, Rong Chen, Raza Malik, Richard E. Reitz, Imad Ahmad Nasser, Nezam H. Afdhal · 2009 · Clinical Gastroenterology and Hepatology
26. Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
    Jessica Katharine Dyson, Stuart McPherson, Quentin Mark Anstee · 2013 · Journal of Clinical Pathology
27. Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in General Population: the French Nationwide NASH-CO Study
    Oumarou Nabi, Karine Lacombe, Jérôme Boursier, Philippe Mathurin, Marie Zins, Lawrence Serfaty · 2020 · Gastroenterology
28. Safety and Effectiveness of Direct-Acting Antiviral Agents for Treatment of Patients With Chronic Hepatitis C Virus Infection and Cirrhosis
    Raoel Maan, Marjolein van Tilborg, Katja Deterding, Alnoor S. Ramji, Adriaan J. van der Meer, Florence Suet-Hing Wong, Scott K. Fung, Morris Sherman, Michael Peter Manns, Markus Cornberg et al. · 2016 · Clinical Gastroenterology and Hepatology
29. Intestinal Failure-Associated Liver Disease
    Loris Pironi, Anna Simona Sasdelli · 2019 · Clinics in Liver Disease
30. Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)
    Kristina Önnerhag, Hannes Hartman, Peter M. Nilsson, Stefan C. Lindgren · 2019 · Scandinavian Journal of Gastroenterology
31. Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study
    Milan J. Sonneveld, Willem Pieter Brouwer, Henry Lik‐Yuen Chan, Teerha Piratvisuth, Jidong Jia, Stefan Zeuzem, Yun‐Fan Liaw, Bettina E. Hansen, Hannah S. J. Choi, Cynthia Wat et al. · 2019 · The Lancet. Gastroenterology & hepatology
32. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
    Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi · 2022 · Diagnostics
33. Prediction of posthepatectomy liver failure based on liver stiffness measurement in patients with hepatocellular carcinoma
    Takahiro Nishio, Kojiro Taura, Yukinori Koyama, Kazutaka Tanabe, Gen Yamamoto, Yukihiro Okuda, Yoshinobu Ikeno, Satoru Seo, Kentaro Yasuchika, Etsuro Hatano et al. · 2015 · Surgery
34. Predictors of de novo nonalcoholic fatty liver disease after liver transplantation and associated fibrosis
    Galvin, Zita, Rajakumar, Ramraj, Chen, Emily, Adeyi, Oyedele, Selzner, Markus, Grant, David, Sapisochin, Gonzalo, Greig, Paul, Cattral, Mark, McGilvray, Ian et al. · 2019 · Liver Transplantation
35. FibroGENE: A gene-based model for staging liver fibrosis
    Mohammed Eslam, Ahmed M. Hashem, Manuel Romero‐Gómez, Thomas Berg, Gregory J. Dore, Alessandra Mangia, Henry Lik‐Yuen Chan, William Lucien Irving, David A. Sheridan, Maria Lorena Abate et al. · 2015 · Journal of Hepatology
36. Liver fibrosis markers of nonalcoholic steatohepatitis
    Hirayuki Enomoto · 2015 · World Journal of Gastroenterology
37. KASL clinical practice guidelines: management of hepatitis C
    2016 · Clinical and Molecular Hepatology
38. Surveillance for liver complications after the Fontan procedure
    Moira B. Hilscher, Jonathan N. Johnson, Frank Cetta, David J. O. Driscoll, John J. Poterucha, William Sánchez, Heidi M. Connolly, Patrick S. Kamath · 2017 · Congenital Heart Disease
39. Cost effectiveness of different strategies for detecting cirrhosis in patients with nonalcoholic fatty liver disease based on United States health care system
    Vilar-Gomez, Eduardo, Lou, Zhouyang, Kong, Nan, Vuppalanchi, Raj, Imperiale, Thomas F., Chalasani, Naga · 2020 · Clinical Gastroenterology and Hepatology
40. The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
    Mikkel Parsberg Werge, Adrian McCann, Elisabeth Douglas Galsgaard, Dorte Holst, Anne K. Bugge, Nicolai J. Wewer Albrechtsen, Lise Lotte Gluud · 2021 · Journal of Clinical Medicine
41. EASL position paper on clinical follow-up after HCV cure
    Thomas Reiberger, Sabela Lens, Giuseppe Cabibbo, Pierre Nahon, Anna Linda Zignego, Katja Deterding, Ahmed Mohamed Elsharkawy, Xavier Forns · 2024 · Journal of Hepatology
42. A New Model Using Routinely Available Clinical Parameters to Predict Significant Liver Fibrosis in Chronic Hepatitis B
    Wai‐Kay Seto, Chun-Fan Lee, Ching‐Lung Lai, Philip P.C. Ip, Dyt Fong, James Fung, Danny K.-H. Wong, Man‐Fung Yuen · 2011 · PLoS ONE
43. Diagnostic Accuracy of Noninvasive Markers of Steatosis, NASH, and Liver Fibrosis in HIV-Monoinfected Individuals at Risk of Nonalcoholic Fatty Liver Disease (NAFLD): Results From the ECHAM Study
    Maud Lemoine, Lambert Assoumou, Stephane De Wit, Pierre‐Marie Girard, Marc‐Antoine Valantin, Christine Katlama, Coca Necsoi, Pauline Campa, Anja Hüfner, Julian Schulze zur Wiesch et al. · 2018 · JAIDS Journal of Acquired Immune Deficiency Syndromes
44. Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents
    Wei‐Fan Hsu, Hsueh‐Chou Lai, Wen‐Pang Su, Chia‐Hsin Lin, Po‐Heng Chuang, Sheng‐Hung Chen, Hung‐Yao Chen, Hung‐Wei Wang, Guan‐Tarn Huang, Cheng‐Yuan Peng · 2019 · BMC Gastroenterology
45. Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories
    Stefano Ciardullo, Tommaso Monti, Isabella Sala, Guido M. Grassi, Giuseppe Mancia, Gianluca Perseghin · 2020 · Hypertension
46. Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis
    Jia‐Cheng Liu, Jian Wang, Xiaomin Yan, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yilin Liu, Minxin Mao, Juan Xia et al. · 2021 · Hepatology Communications
47. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis
    Antonio Liguori, Mirko Zoncapè, Giovanni Casazza, Philippa Easterbrook, Emmanuel A. Tsochatzis · 2025 · The Lancet. Gastroenterology & hepatology
48. A novel noninvasive diagnostic method for nonalcoholic steatohepatitis using two glycobiomarkers
    Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, Hideki Fujii, Yoshio Sumida, Kojiroh Mori, Saiyu Tanaka, Makoto Yamada, Maaya Akita, Kayo Mizutani et al. · 2015 · Hepatology
49. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis
    Yoshihiro Kamada, Maaya Akita, Yuri Takeda, Shin Yamada, Hideki Fujii, Yoshiyuki Sawai, Yoshinori Doi, Hitomi Asazawa, Kotarosumitomo Nakayama, Kayo Mizutani et al. · 2013 · PLoS ONE
50. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non‐alcoholic fatty liver disease
    Naoshi Nishida, Norihisa Yada, Satoru Hagiwara, Toshiharu Sakurai, Masayuki Kitano, Masatoshi Kudo · 2016 · Journal of Gastroenterology and Hepatology
51. Evaluation of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis
    Qinyu Xu, Sheng Li, Han Bao, Xiaoyu Chen, Can‐Jie Guo, Hai Li, Xiong Ma, Dekai Qiu, Jing Hua · 2016 · Journal of Gastroenterology and Hepatology
52. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients
    Julie Bottero, Karine Lacombe, Jérôme Guechot, Lawrence Serfaty, Patrick Miailhes, Philippe Bonnard, Dominique Wendum, Jean‐Michel Molina, Caroline Lascoux‐Combe, Pierre‐Marie Girard · 2009 · Journal of Hepatology
53. Transient elastography for diagnosis of portal hypertension in liver cirrhosis
    Joseph K. Lim, Roberto J. Groszmann · 2007 · Hepatology
54. Validation and Comparison of Simple Noninvasive Indexes for Predicting Liver Fibrosis in HIV-HCV-Coinfected Patients: ANRS CO3 Aquitaine Cohort
    Marc‐Arthur Loko, Laurent Castéra, François Dabis, Brigitte Le Bail, María Winnock, Gaëlle Coureau, Paulette Bioulac‐Sage, Victor de Lédinghen, Didier Neau, the Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)1,3 · 2008 · The American Journal of Gastroenterology
55. Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
    Jung Hwan Yu, Young Ju Suh, Young‐Joo Jin, Nae‐Yun Heo, Ji Woong Jang, Chan Ran You, Hyun Young An, Jin‐Woo Lee · 2019 · European Journal of Gastroenterology & Hepatology
56. Comparison of FIB ‐4 and APRI in Chinese HBV ‐infected patients with persistently normal ALT and mildly elevated ALT
    H. Wang, Xue Li, Rong Yan, Yin Zhou, M. S. Wang, Meijuan Cheng, Haijun Huang · 2012 · Journal of Viral Hepatitis
57. Oral Diseases Associated with Nonalcoholic Fatty Liver Disease in the United States
    Jane A. Weintraub, Gabriela Lopez Mitnik, Bruce A. Dye · 2019 · Journal of Dental Research
58. FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
    Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono et al. · 2021 · Life
59. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America
    Marc G. Ghany, Wendy C. King, Mauricio Lisker‐Melman, Anna Suk-Fong Lok, Norah A. Terrault, Harry L.A. Janssen, Mandana Khalili, Raymond T. Chung, William M. Lee, Daryl Lau et al. · 2021 · Hepatology
60. Quantification of Liver Surface Nodularity at CT: Utility for Detection of Portal Hypertension
    Riccardo Sartoris, Pierre‐Emmanuel Rautou, Laure Elkrief, Gaia Pollorsi, François Durand, Dominique Charles Valla, Laurent Spahr, Sylvain Terraz, Olivier Soubrane, François Cauchy et al. · 2018 · Radiology
61. Albumin–bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C
    Koji Fujita, Kyoko Oura, Hirohito Yoneyama, Tingting Shi, Kei Takuma, M. Nakahara, Tomoko Tadokoro, Takako Nomura, Asahiro Morishita, Kunihiko Tsutsui et al. · 2019 · Hepatology Research
62. Impact of hepatitis C virus eradication on hepatocellular carcinogenesis
    Darrick K. Li, Raymond T. Chung · 2015 · Cancer
63. Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods
    Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuji Ogawa, Yuichiro Eguchi, Yoshio Sumida, Masashi Yoneda, Miwa Kawanaka, Satoru Saito, Katsutoshi Tokushige et al. · 2017 · Journal of Gastroenterology
64. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
    Alejandro Campos-Murguía, Astrid Ruiz‐Margáin, José Alberto González-Regueiro, Ricardo Ulises Macías‐Rodríguez · 2020 · World Journal of Gastroenterology
65. Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
    Ying Qu, Yanyan Song, Chengwei Chen, Qingchun Fu, Junping Shi, Yun Xu, Qing Xie, Yongfeng Yang, Yongjian Zhou, Liang-Ping Li et al. · 2021 · Clinical and Translational Gastroenterology
66. Impact of hepatitis B virus infection on metabolic profiles and modifying factors
    Ching‐Sheng Hsu, Chen‐Hua Liu, Chia‐Chi Wang, Tai‐Chung Tseng, Chun‐Jen Liu, C.‐L. Chen, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao · 2011 · Journal of Viral Hepatitis
67. Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy
    Stella M. Martinez, Juliette Foucher, Jean-Marc Combis, Sophie Métivier, Maurizia Rossana Brunetto, Dominique Capron, Marc Bourlière, Jean–Pierre Bronowicki, Thông Dao, Marianne Maynard et al. · 2012 · PLoS ONE
68. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study
    Jason Grebely, Maryam Alavi, Michelle A. Micallef, Adrian John Dunlop, Anne Balcomb, Nghi Phung, Martin Weltman, Carolyn Day, Carla Treloar, Nicky Bath et al. · 2015 · Addiction
69. Non‐alcoholic fatty liver diseases and risk of colorectal neoplasia
    Joonghyun Ahn, Dong Hyun Sinn, Yang Won Min, Sung Noh Hong, H. S. Kim, Sin‐Ho Jung, Seonhye Gu, Poong‐Lyul Rhee, Seung Woon Paik, Hee Jung Son et al. · 2016 · Alimentary Pharmacology & Therapeutics
70. HCC risk post-SVR with DAAs in East Asians: findings from the REAL-C cohort
    For the REAL-C Investigators, Yasuhito Tanaka, Eiichi Ogawa, Chung‐Feng Huang, Hidenori Toyoda, Dae Won Jun, Cheng‐Hao Tseng, Yao‐Chun Hsu, Masaru Enomoto, Hirokazu Takahashi et al. · 2020 · Hepatology International
71. Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population
    Mette Juul Nielsen, Diana Julie Leeming, Zachary D Goodman, Scott L. Friedman, Peder Frederiksen, Daniel Guldager Kring Rasmussen, Pamela Vig, Star Seyedkazemi, Laurent Fischer, Richard Torstenson et al. · 2021 · Journal of Hepatology
72. Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone
    Jian Wang, Xiaomin Yan, Li Zhu, Jiacheng Liu, Yuanwang Qiu, Yiguang Li, Yilin Liu, Ruifei Xue, Jie Zhan, Suling Jiang et al. · 2022 · Alimentary Pharmacology & Therapeutics
73. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States
    Samer Gawrieh, Eduardo Vilar‐Gómez, Tinsay A. Woreta, Jordan E. Lake, Laura Wilson, Jennifer C. Price, Susanna Naggie, Richard K. Sterling, Sonya L. Heath, Kathleen E. Corey et al. · 2023 · Alimentary Pharmacology & Therapeutics
74. Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD
    Lars Verschuren, Anne Linde Mak, Arianne van Koppen, Serdar Özsezen, Sonia Difrancesco, Martien P. M. Caspers, Jessica M. Snabel, David van der Meer, Anne‐Marieke van Dijk, Elias Badal Rashu et al. · 2024 · Nature Communications
75. Nonalcoholic Fatty Liver Disease
    Angelo H. Paredes, Dawn McDowell Torres, Stephen A. Harrison · 2012 · Clinics in Liver Disease
76. High titers of anti‐HBs prevent rituximab‐related viral reactivation in resolved hepatitis B patient with non‐Hodgkin's lymphoma
    Yuri Cho, Su Jong Yu, Eun Ju Cho, Jeong‐Hoon Lee, Tae Min Kim, Dae Seog Heo, Yoon Jun Kim, Jung‐Hwan Yoon · 2015 · Journal of Medical Virology
77. Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients
    Alessandro Federico, Marcello Dallio, Mario Masarone, Antonietta Gerarda Gravina, Rosa Di Sarno, Concetta Tuccillo, Valentina Cossiga, Stefania Lama, Paola Stiuso, Filomena Morisco et al. · 2019 · Oxidative Medicine and Cellular Longevity
78. Markers of Collagen Remodeling Detect Clinically Significant Fibrosis in Chronic Hepatitis C Patients
    Mette Juul Nielsen, Konstantin Kazankov, Diana Julie Leeming, M.A. Karsdal, Aleksander Ahm Krag, Francisco Barrera M., Duncan J. McLeod, Jacob George, Henning Grønbæk · 2015 · PLoS ONE
79. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018
    Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, David H. Ballard, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber R. Salter, Allan Tsung, Anup S. Shetty et al. · 2019 · Abdominal Radiology
80. Fibroscan Compared to FIB-4, APRI, and AST/ALT Ratio for Assessment of Liver Fibrosis in Saudi Patients With Nonalcoholic Fatty Liver Disease
    Hind I. Fallatah, Hisham Osman Akbar, Alyaa M. Fallatah · 2016 · Hepatitis Monthly
81. Systematic review: diagnostic accuracy of non-invasive tests for staging liver fibrosis in autoimmune hepatitis
    Shanshan Wu, Zhirong Yang, Jialing Zhou, Na Zeng, Zhiying He, Siyan Zhan, Jidong Jia, Hong You · 2018 · Hepatology International
82. The WHO guidelines for chronic hepatitis B fail to detect half of the patients in need of treatment in Ethiopia
    Hanna Aberra, Hailemichael Desalegn, Nega Berhe, Bitsatab Mekasha, Girmay Medhin, Svein Gunnar Gundersen, Asgeir Johannessen · 2019 · Journal of Hepatology
83. Elevation of Liver Fibrosis Index FIB-4 Is Associated With Poor Clinical Outcomes in Patients With COVID-19
    Luis Ibáñez, Federico Bighelli, Clara Usón, Celia Caravaca Gámez, Carlos Fernández‐Carrillo, Míriam Romero, Mónica Barreales, Christie Perelló, Antonio Madejón, Aránzazu Caballero Marcos et al. · 2020 · The Journal of Infectious Diseases
84. Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
    Roger Chou, Ngoc Wasson · 2013 · Annals of Internal Medicine
85. Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut‐Off Approach
    Cristoferi, Laura, Calvaruso, Vincenza, Overi, Diletta, Viganò, Mauro, Rigamonti, Cristina, Degasperi, Elisabetta, Cardinale, Vincenzo, Labanca, Sara, Zucchini, Nicola, Fichera, Anna et al. · 2021 · Hepatology
86. Serial changes in liver stiffness and controlled attenuation parameter following direct‐acting antiviral therapy against hepatitis C virus genotype 1b
    Nobuhiko Ogasawara, Masahiro Kobayashi, Norio Akuta, Yoko Kominami, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Fumitaka Suzuki, Satoshi Saitoh et al. · 2017 · Journal of Medical Virology
87. Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients
    Evrim Anadol, Robert Schierwagen, N Elfimova, Katharina Tack, Carolynne Schwarze‐Zander, H Eischeid, A Noetel, Christoph Boesecke, Christian Jansen, Leona Dold et al. · 2014 · Hepatology
88. Eradication of hepatitis C virus and non‐liver‐related non–acquired immune deficiency syndrome–related events in human immunodeficiency virus/hepatitis C virus coinfection
    Juan Berenguer, Elena Rodríguez‐Castellano, Ana Carrero, Miguel Ángel von Wichmann, Marta Montero, Marı́a José Galindo, Josep Mallolas, M. Crespo Casal, María Jesús Téllez, Carmen Quereda et al. · 2017 · Hepatology
89. Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade
    Albert Do, Yash Mittal, AnnMarie Liapakis, Elizabeth Cohen, Hong Chau, Claudia Alejandra Bertuccio, Dana Sapir, Jessica A. Wright, Carol A. Eggers, Kristine Drozd et al. · 2015 · PLoS ONE
90. Regression of liver fibrosis after curing chronic hepatitis C with oral antivirals in patients with and without HIV coinfection
    Gema Maria Lledó, Itzíar Carrasco, Laura Benítez‐Gutiérrez, Ana Arias, Ana Royuela, Silvia Requena, Valentín Cuervas‐Mons, Carmen de Mendoza · 2018 · AIDS
91. Simultaneous EUS-guided portosystemic pressure measurement and liver biopsy sampling correlate with clinically meaningful outcomes
    Kaveh Hajifathalian, Donevan Westerveld, Alyson J. Kaplan, Enad Dawod, Andrea Herr, Mallory Ianelli, Allysa Saggese, Sonal Rajesh Kumar, Brett E. Fortune, Reem Z. Sharaiha · 2021 · Gastrointestinal Endoscopy
92. Utility of real‐time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis C infection without cirrhosis: Comparison of liver fibrosis indices
    Toshifumi Tada, Takashi Kumada, Hidenori Toyoda, Takanori Ito, Yasuhiro Sone, Seiji Okuda, Nozomi Tsuji, Yumi Imayoshi, Eisuke Yasuda · 2015 · Hepatology Research
93. Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection
    Prowpanga Udompap, Ajitha Mannalithara, Nae‐Yun Heo, Donghee Kim, W. Ray Kim · 2016 · Journal of Hepatology
94. First-in-Asian double-blind randomized trial to assess the efficacy and safety of insulin sensitizer in nonalcoholic steatohepatitis patients
    2021
95. Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long‐Term Home Parenteral Nutrition
    A. Van Gossum, Loris Pironi, Bernard Messing, Christophe Moreno, Antonio Colecchia, Antonietta D’Errico, Pieter Demetter, Françoise De Gos, Dominique L. Cazals-Hatem, Francisca Joly · 2014 · Journal of Parenteral and Enteral Nutrition
96. Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
    Tomoo Yamazaki, Satoru Joshita, Takeji Umemura, Yoko Usami, Ayumi Sugiura, Naoyuki Fujimori, Soichiro Shibata, Yuki Ichikawa, Michiharu Komatsu, Akihiro Matsumoto et al. · 2017 · Scientific Reports
97. Serum ferritin level is associated with liver steatosis and fibrosis in Korean general population
    Ju Young Jung, Jae‐Jun Shim, Sung Keun Park, Jae‐Hong Ryoo, Joong‐Myung Choi, In‐Hwan Oh, Kyu‐Won Jung, Hyunsoon Cho, Moran Ki, Young‐Joo Won et al. · 2018 · Hepatology International
98. Chapter 4 Biomarkers Of Liver Fibrosis
    Thierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert‐Bismut, Dominique Thabut, Djamila Messous, Mona Munteanu, Julien Massard, Yves Benhamou, Vlad Ratziu · 2008 · Advances in clinical chemistry
99. HIV Monoinfection Is Associated With Increased Aspartate Aminotransferase-to-Platelet Ratio Index, a Surrogate Marker for Hepatic Fibrosis
    Jennifer C. Price, Eric C. Seaberg, Sheila M. Badri, Mallory D. Witt, Kristin DʼAcunto, Chloe L. Thio · 2012 · The Journal of Infectious Diseases
100. Prevalence of pruritus in patients with chronic liver disease: A multicenter study
     Satoshi Oeda, Hirokazu Takahashi, Hisako Yoshida, Yuji Ogawa, Kento Imajo, Masato Yoneda, Yuichi Koshiyama, Masafumi Ono, Hideyuki Hyogo, Takumi Kawaguchi et al. · 2017 · Hepatology Research